{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:08:39Z","timestamp":1790446119572,"version":"4.1.0"},"reference-count":91,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Meissa Vaccines Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives: The emergence of SARS-CoV-2 variants and breakthrough infections underscores the need for next-generation vaccines capable of protecting from natural infection and\/or preventing virus transmission. Intranasal vaccination offers a promising approach by eliciting local immune responses in the nasal mucosa, the primary site of infection and reservoir for transmissible virus. We evaluated two live-attenuated, respiratory syncytial virus-vectored vaccines in which the RSV F and G surface glycoproteins were replaced with a chimeric SARS-CoV-2 Spike protein from the ancestral USA\/WA-1\/2020 strain (MV-014-212) or the Delta variant (MV-014-212-delta). Methods: K18-hACE2 mice and LVG Syrian hamsters were vaccinated with a single intranasal dose of MV-014-212 or MV-014-212-delta. Systemic and mucosal immunity were assessed following vaccination, and protection was evaluated following Delta SARS-CoV-2 challenge. In vaccinated hamsters, morbidity, viral shedding, and lung inflammation and injury were also assessed following natural exposure to infected cagemates. Results: A single intranasal dose of either vaccine elicited systemic and mucosal immunity in K18-hACE2 mice, including serum neutralizing antibodies, Spike-specific memory B cells and plasmablasts, and Spike-specific CD8+ lung-resident memory T cells. Although MV-014-212-delta vaccination provided the best protection against the Delta variant virus challenge, both vaccines decreased viral loads in nasal discharge, lung, and brain, and reduced weight loss and mortality. In naturally acquired infection studies, vaccinated hamsters exposed to infected cagemates exhibited minimal weight loss, limited viral replication within the nasal mucosa, and attenuated lung pathology. Conclusions: Intranasal RSV-vectored vaccines can elicit broad protective respiratory immunity, suggesting that this platform could be leveraged for other respiratory pathogens.<\/jats:p>","DOI":"10.3390\/vaccines14050399","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:01:18Z","timestamp":1777474878000},"page":"399","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intranasal Immunization with Live-Attenuated RSV-Vectored SARS-CoV-2 Vaccines Elicits Antigen-Specific Systemic and Mucosal Immunity and Protects Against Viral Challenge and Natural Infection"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3926-0662","authenticated-orcid":false,"given":"Davide","family":"Botta","sequence":"first","affiliation":[{"name":"Department of Microbiology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"HSOM Immunology Institute, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6741-4115","authenticated-orcid":false,"given":"Michael D.","family":"Schultz","sequence":"additional","affiliation":[{"name":"Department of Microbiology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Silva-Sanchez","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davies","family":"Kalange","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-3663","authenticated-orcid":false,"given":"Jobaida","family":"Akther","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Microbiology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Tipper","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6103-8836","authenticated-orcid":false,"given":"Guang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Microbiology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0822-0257","authenticated-orcid":false,"given":"Levi T.","family":"Schaefers","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Laboratory Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney A.","family":"Barkley","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihong","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Microbiology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy B.","family":"Foote","sequence":"additional","affiliation":[{"name":"Department of Microbiology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7865-3023","authenticated-orcid":false,"given":"Mariana F.","family":"Tioni","sequence":"additional","affiliation":[{"name":"Meissa Vaccines Inc., Redwood City, CA 94065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4704-9533","authenticated-orcid":false,"given":"Christopher M.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Meissa Vaccines Inc., Redwood City, CA 94065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon I.","family":"Phan","sequence":"additional","affiliation":[{"name":"Meissa Vaccines Inc., Redwood City, CA 94065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-4710","authenticated-orcid":false,"given":"Todd J.","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Microbiology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Sixto M.","family":"Leal","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Laboratory Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0780-9470","authenticated-orcid":false,"given":"Kevin S.","family":"Harrod","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6522-0053","authenticated-orcid":false,"given":"Rodney G.","family":"King","sequence":"additional","affiliation":[{"name":"Department of Microbiology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L.","family":"Moore","sequence":"additional","affiliation":[{"name":"Meissa Vaccines Inc., Redwood City, CA 94065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy D.","family":"Randall","sequence":"additional","affiliation":[{"name":"HSOM Immunology Institute, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Department of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick S.","family":"Tang","sequence":"additional","affiliation":[{"name":"Meissa Vaccines Inc., Redwood City, CA 94065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3083-1246","authenticated-orcid":false,"given":"Frances E.","family":"Lund","sequence":"additional","affiliation":[{"name":"Department of Microbiology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"HSOM Immunology Institute, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"ref_1","unstructured":"(2026, January 26). WHO Coronavirus (COVID-19) Dashboard. Available online: https:\/\/covid19.who.int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J. Autoimmun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMc2004973","article-title":"Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1","volume":"382","author":"Bushmaker","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.immuni.2022.10.017","article-title":"Sterilizing immunity: Understanding COVID-19","volume":"55","author":"Wahl","year":"2022","journal-title":"Immunity"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Focosi, D., Maggi, F., and Casadevall, A. (2022). Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence. Viruses, 14.","DOI":"10.3390\/v14020187"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Schultz, M.D., Botta, D., Silva-Sanchez, A., Cheatwood, I.R., Kalange, D., Terapane, S.M., Lucander, A.C.K., Zhou, F., Akther, J., and Yang, G. (2025). Mucosal delivery of influenza antigens using a replication deficient adenovirus supports broadly reactive antibody responses and heterologous viral immunity in the respiratory tract of animals. bioRxiv.","DOI":"10.1101\/2025.10.13.682194"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/immuno2040036","article-title":"Harnessing Nasal Immunity with IgA to Prevent Respiratory Infections","volume":"2","author":"Joseph","year":"2022","journal-title":"Immuno"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/trf.16435","article-title":"Are We Forgetting About IgA? A Re-examination of Coronavirus Disease 2019 Convalescent Plasma","volume":"61","author":"Verkerke","year":"2021","journal-title":"Transfusion"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/infdis\/jiae447","article-title":"Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom Resolution","volume":"231","author":"Pisanic","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4049\/immunohorizons.2000067","article-title":"Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection","volume":"5","author":"Luangrath","year":"2021","journal-title":"Immunohorizons"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"102278","DOI":"10.1016\/j.coi.2022.102278","article-title":"Lung tissue-resident memory T cells: The gatekeeper to respiratory viral (re)-infection","volume":"80","author":"Tang","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41590-018-0260-6","article-title":"The establishment of resident memory B cells in the lung requires local antigen encounter","volume":"20","author":"Allie","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/14760584.2024.2326094","article-title":"Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines","volume":"23","author":"Zhang","year":"2024","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_14","unstructured":"(2026, January 23). CanSinoBIO\u2019s Convidecia Air\u2122 Approved for Emergency Use in Morocco. Available online: http:\/\/47.99.161.107\/detail-3927."},{"key":"ref_15","unstructured":"(2026, January 23). CanSinoBIO\u2019s Convidecia Air\u2122 Receives Approval in China. Available online: http:\/\/47.99.161.107\/detail-3931."},{"key":"ref_16","unstructured":"(2026, January 23). CanSinoBIO\u2019s Convidecia Air\u00ae Receives Approval in Indonesia. Available online: http:\/\/47.99.161.107\/detail-3941."},{"key":"ref_17","unstructured":"Biotech, B. (2026, January 23). Bharat Biotech\u2019s iNCOVACC World\u2019s First Intra Nasal Vaccine Receives Approval for Emergency Use in India. Available online: https:\/\/www.bharatbiotech.com\/images\/press\/Bharat-Biotech-iNCOVACC-Worlds-First-Intra-Nasal-Vaccine-Receives-Approval.pdf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"127356","DOI":"10.1016\/j.vaccine.2025.127356","article-title":"A review of currently licensed mucosal COVID-19 vaccines","volume":"61","author":"Tscherne","year":"2025","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1080\/21645515.2018.1461296","article-title":"Noninvasive vaccination against infectious diseases","volume":"14","author":"Zheng","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_20","unstructured":"Kolhe, P., and Ohtake, S. (2022). 12\u2014Conventional and Nontraditional Delivery Methods and Routes of Vaccine Administration, Academic Press."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e171797","DOI":"10.1172\/JCI171797","article-title":"SARS-CoV-2 mRNA vaccination-induced immunological memory in human nonlymphoid and lymphoid tissues","volume":"133","author":"Pross","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s13577-021-00512-4","article-title":"COVID-19 vaccines: Rapid development, implications, challenges and future prospects","volume":"34","author":"Kashte","year":"2021","journal-title":"Hum. Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/21645515.2015.1114195","article-title":"Induction of mucosal immunity through systemic immunization: Phantom or reality?","volume":"12","author":"Su","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"120686","DOI":"10.1016\/j.ijpharm.2021.120686","article-title":"Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?","volume":"603","author":"Tiboni","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/s41467-023-37559-w","article-title":"Limited induction of polyfunctional lung-resident memory T cells against SARS-CoV-2 by mRNA vaccination compared to infection","volume":"14","author":"Pieren","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41577-020-00477-9","article-title":"Regulation of immune responses by the airway epithelial cell landscape","volume":"21","author":"Hewitt","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e148517","DOI":"10.1172\/JCI148517","article-title":"Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19","volume":"131","author":"Ahn","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1016\/j.vaccine.2007.06.017","article-title":"Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice","volume":"25","author":"Hu","year":"2007","journal-title":"Vaccine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.180.2.948","article-title":"Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection","volume":"180","author":"Du","year":"2008","journal-title":"J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"109400","DOI":"10.1016\/j.celrep.2021.109400","article-title":"A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters","volume":"36","author":"Bricker","year":"2021","journal-title":"Cell Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100230","DOI":"10.1016\/j.xcrm.2021.100230","article-title":"A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques","volume":"2","author":"Hassan","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e180784","DOI":"10.1172\/jci.insight.180784","article-title":"An intranasally administered adenovirus-vectored SARS-CoV-2 vaccine induces robust mucosal secretory IgA","volume":"9","author":"Sun","year":"2024","journal-title":"JCI Insight"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zhang, R., Chan, K.H., Wang, P., Zhou, R., Yau, H.K., Wong, C.K., Au, M.W., Tam, A.R., Ng, C.T., and Lou, M.K. (2023). A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults. Vaccines, 11.","DOI":"10.3390\/vaccines11040723"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-024-01906-0","article-title":"Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct. Tar."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41541-022-00509-6","article-title":"Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2","volume":"7","author":"Tioni","year":"2022","journal-title":"NPJ Vaccines"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Rosenberg, A., Killian, J., Green, T.J., Akther, J., Hossain, M., Qiu, S., Randall, T., Lund, F., and King, R.G. (2023). A high-throughput multiplex array for antigen-specific serology with automated analysis. bioRxiv.","DOI":"10.1101\/2023.03.29.534777"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"King, R.G., Silva-Sanchez, A., Peel, J.N., Botta, D., Dickson, A.M., Pinto, A.K., Meza-Perez, S., Allie, S.R., Schultz, M.D., and Liu, M. (2021). Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge. Vaccines, 9.","DOI":"10.3390\/vaccines9080881"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2127292","DOI":"10.1080\/21645515.2022.2127292","article-title":"A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts","volume":"18","author":"Schultz","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jviromet.2010.08.006","article-title":"Generation of VSV pseudotypes using recombinant DeltaG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines","volume":"169","author":"Whitt","year":"2010","journal-title":"J. Virol. Methods"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2020.06.021","article-title":"Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Carroll, T., Fox, D., van Doremalen, N., Ball, E., Morris, M.K., Sotomayor-Gonzalez, A., Servellita, V., Rustagi, A., Yinda, C.K., and Fritts, L. (2022). The B.1.427\/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters. PLoS Pathog., 18.","DOI":"10.1101\/2021.08.25.457626"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1165\/rcmb.2020-0280LE","article-title":"Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2-infected Hamsters: What Matters?","volume":"63","author":"Gruber","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e184074","DOI":"10.1172\/jci.insight.184074","article-title":"Tissue-resident memory T cells contribute to protection against heterologous SARS-CoV-2 challenge","volume":"9","author":"Odle","year":"2024","journal-title":"JCI Insight"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41385-021-00461-z","article-title":"Tissue resident memory T cells in the respiratory tract","volume":"15","author":"Zheng","year":"2022","journal-title":"Mucosal Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41590-024-02072-9","article-title":"Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs","volume":"26","author":"Zhu","year":"2025","journal-title":"Nat. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","author":"Winkler","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Kumari, P., Rothan, H.A., Natekar, J.P., Stone, S., Pathak, H., Strate, P.G., Arora, K., Brinton, M.A., and Kumar, M. (2021). Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice. Viruses, 13.","DOI":"10.1101\/2020.12.14.422714"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41421-021-00290-1","article-title":"SARS-CoV-2 infection in the mouse olfactory system","volume":"7","author":"Ye","year":"2021","journal-title":"Cell Discov."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2787-6","article-title":"Animal models for COVID-19","volume":"586","author":"Dowling","year":"2020","journal-title":"Nature"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coviro.2021.06.007","article-title":"Animal models of SARS-CoV-2 transmission","volume":"50","author":"Rockx","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","article-title":"Pathogenesis and transmission of SARS-CoV-2 in golden hamsters","volume":"583","author":"Sia","year":"2020","journal-title":"Nature"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1080\/22221751.2020.1858177","article-title":"Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection","volume":"9","author":"Rosenke","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1038\/s41467-021-25156-8","article-title":"SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters","volume":"12","author":"Port","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/cid\/ciaa325","article-title":"Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility","volume":"71","author":"Chan","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/s41467-024-45348-2","article-title":"An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission","volume":"15","author":"Adler","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41564-024-01755-1","article-title":"A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications","volume":"9","author":"Barut","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1038\/s41467-024-51535-y","article-title":"A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"RP97532","DOI":"10.7554\/eLife.97532.3","article-title":"Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms","volume":"13","author":"Okamura","year":"2025","journal-title":"Elife"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"105662","DOI":"10.1016\/j.ebiom.2025.105662","article-title":"A live attenuated SARS-CoV-2 vaccine constructed by dual inactivation of NSP16 and ORF3a","volume":"114","author":"Ye","year":"2025","journal-title":"EBioMedicine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41541-025-01165-2","article-title":"Live attenuated SARS-CoV-2 vaccine OTS-228 demonstrates efficacy, safety, and stability in preclinical model","volume":"10","author":"Britzke","year":"2025","journal-title":"NPJ Vaccines"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0161-5890(01)00025-6","article-title":"Role of natural and immune IgM antibodies in immune responses","volume":"37","author":"Boes","year":"2000","journal-title":"Mol. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/22221751.2020.1766382","article-title":"Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression","volume":"9","author":"Shen","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41591-021-01416-4","article-title":"Delayed production of neutralizing antibodies correlates with fatal COVID-19 (May, 2021, 10.1038\/s41591-021-01355-0)","volume":"27","author":"Lucas","year":"2021","journal-title":"Nat. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"9147","DOI":"10.1038\/s41598-022-12834-w","article-title":"Low SARS-CoV-2 antibody titers may be associated with poor clinical outcomes for patients with severe COVID-19","volume":"12","author":"Takita","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e2202069119","DOI":"10.1073\/pnas.2202069119","article-title":"Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection","volume":"119","author":"Americo","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","article-title":"Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2","volume":"185","author":"Afkhami","year":"2022","journal-title":"Cell"},{"key":"ref_74","first-page":"968","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2 virus","volume":"37","author":"Sterlin","year":"2021","journal-title":"Med. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1016\/j.ymthe.2025.04.007","article-title":"Intranasal replicon SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission","volume":"33","author":"Jennewein","year":"2025","journal-title":"Mol. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cell.2022.01.029","article-title":"T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals","volume":"185","author":"Naranbhai","year":"2022","journal-title":"Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-023-06937-1","article-title":"Prevention of respiratory virus transmission by resident memory CD8(+) T cells","volume":"626","author":"Uddback","year":"2024","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e01047-14","DOI":"10.1128\/mBio.01047-14","article-title":"Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA","volume":"5","author":"Lin","year":"2014","journal-title":"mBio"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMoa2115481","article-title":"Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines","volume":"386","author":"Andrews","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1473-3099(21)00648-4","article-title":"Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: A prospective, longitudinal, cohort study","volume":"22","author":"Singanayagam","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1056\/NEJMoa2116597","article-title":"Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants","volume":"386","author":"Eyre","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant REPLY","volume":"385","author":"Bernal","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.abl8506","article-title":"Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants","volume":"374","author":"McCallum","year":"2021","journal-title":"Science"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2412643","DOI":"10.1080\/22221751.2024.2412643","article-title":"Neutralisation resistance of SARS-CoV-2 spike-variants is primarily mediated by synergistic receptor binding domain substitutions","volume":"13","author":"Pham","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"115941","DOI":"10.1016\/j.celrep.2025.115941","article-title":"Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike protein","volume":"44","author":"Feng","year":"2025","journal-title":"Cell Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Tada, T., Zhou, H., Samanovic, M.I., Dcosta, B.M., Cornelius, A., Herati, R.S., Mulligan, M.J., and Landau, N.R. (2022). Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.797589"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines\u2014Fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1038\/s41467-024-50133-2","article-title":"Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters","volume":"15","author":"Leekha","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"16587","DOI":"10.1073\/pnas.2009799117","article-title":"Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development","volume":"117","author":"Imai","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s44298-025-00092-2","article-title":"Pathogenesis and transmission of SARS-CoV-2 D614G, Alpha, Gamma, Delta, and Omicron variants in golden hamsters","volume":"3","author":"Banete","year":"2025","journal-title":"NPJ Viruses"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/5\/399\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:21:46Z","timestamp":1777476106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/5\/399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":91,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["vaccines14050399"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14050399","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}